EPLINα controls integrin recycling from Rab21 endosomes to drive breast cancer cell migration

Niklas Z. Jäntti , Paulina Moreno-Layseca, Megan R Chastney, Michal Dibus, James R W Conway, Veli-Matti Leppänen, Hellyeh Hamidi, Kathrin Eylmann, Leticia Oliveira-Ferrer, Stefan Veltel, Johanna Ivaska

Dev Cell. 2025

ABSTRACT

Epithelial protein lost in neoplasm (EPLIN), an actin-binding protein, has been described as both a tumor promoter and tumor suppressor in different cancers. The roles of EPLIN isoforms (α/β) remain largely unknown and could explain these opposing views. We observed distinct EPLIN isoform localization in breast cancer cells; EPLINα is recruited to actin in plasma membrane ruffles and endosomes, while EPLINβ resides on stress fibers. EPLINα localizes to early endosomes in an actin-dependent manner, where it interacts with Rab21, an established regulator of β1-integrin endosomal trafficking. This supports β1-integrin recycling and cell migration. Using proximity biotinylation (BioID), we identified coronin 1C as an EPLIN-proximal protein, which also localizes at Rab21-containing endosomes and controls integrin recycling downstream of EPLINα. EPLINα expression was linked to increased breast cancer cell motility, and a high EPLINα-to-EPLINβ ratio correlated with a mesenchymal phenotype in patient samples. Our work identifies previously unknown EPLIN-isoform-specific functions relevant to breast cancer and beyond.

PMID: 40669465 | DOI: 10.1016/j.devcel.2025.06.025